A scientist discovered and identified a problem protein that is responsible for promoting ALS in over 80% of PALS. This problem protein was previously unknown by researchers around the world. The RCH4 Charity then designed a drug that safely stops the production of this problem protein with no known side effects in patients.
Please visit the RCH4 Charity, but please keep in mind the charities website is not the easiest or most organized. It does however contain very pertinent information.
RCH4 is a drug administered by a intramuscular injection twice a week. It is administered using a syringe and needle more commonly used to inject insulin in the treatment of diabetes.
At this time the exact compounds and how or why they work are currently patented, but not available until a proper investor is found to bring RCH4 through trials and to the global marketplace.